Back to trial detailsIntake questionnaire
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Applying to GenesisCare USA - Fort Apache · Las Vegas, Nevada
Answer a few short questions to share with the research team.
0 of 3 answered